Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1997 Nov;151(5):1437–1446.

Mononuclear phagocyte hydrolytic enzyme activity associated with cerebral HIV-1 infection.

B B Gelman 1, D A Wolf 1, M Rodriguez-Wolf 1, A B West 1, A K Haque 1, M Cloyd 1
PMCID: PMC1858071  PMID: 9358770

Abstract

In patients with HIV encephalitis, activated macrophages and microglial cells in the brain are infected by the human immunodeficiency virus (HIV-1). Immune activation can release neurotoxic chemicals including cytokines, free radicals, autocoids, and hydrolytic enzymes. In this study, the presence of hydrolytic enzymes in acquired immune deficiency syndrome (AIDS)-related neurodegeneration was addressed. Activities of four lysosomal hydrolases were assayed in the frontal lobe of 69 males who died with AIDS and 31 age-matched control men. Activities of all four enzymes were increased significantly (1.6 to 3.6 times) in white matter of patients with AIDS. Less pronounced increases were present in cerebral cortex. Of 69 of the subjects with AIDS, 50 (72%), had at least one abnormally active enzyme. Patients with HIV encephalitis and other neuropathological changes were affected as were many subjects without any clear neuropathological anomaly. Lysosomal cathepsin D immunostaining revealed increased lysosomes within perivascular macrophages, multinucleated cells, activated microglial cells, and hypertrophic astrocytes. Increased enzyme activity was correlated significantly with assay results for HIV-1 DNA using the polymerase chain reaction. The release of acid hydrolases associated with cerebral HIV-1 infection could lead to unopposed hydrolysis of matrix and surface proteins. These post-translational disturbances could contribute to white matter and synaptic injury in AIDS.

Full text

PDF
1437

Images in this article

1439Figure 2
on p.1439
1440Figure 3
on p.1440
1442Figure 5
on p.1442

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abu-Alfa A. K., Kuan S. F., West A. B., Reyes-Múgica M. Cathepsin D in intestinal ganglion cells. A potential aid to diagnosis in suspected Hirschsprung's disease. Am J Surg Pathol. 1997 Feb;21(2):201–205. doi: 10.1097/00000478-199702000-00010. [DOI] [PubMed] [Google Scholar]
  2. Achim C. L., Wang R., Miners D. K., Wiley C. A. Brain viral burden in HIV infection. J Neuropathol Exp Neurol. 1994 May;53(3):284–294. doi: 10.1097/00005072-199405000-00010. [DOI] [PubMed] [Google Scholar]
  3. Adams D. O. Effector mechanisms of cytolytically activated macrophages. I. Secretion of neutral proteases and effect of protease inhibitors. J Immunol. 1980 Jan;124(1):286–292. [PubMed] [Google Scholar]
  4. Adamson D. C., Dawson T. M., Zink M. C., Clements J. E., Dawson V. L. Neurovirulent simian immunodeficiency virus infection induces neuronal, endothelial, and glial apoptosis. Mol Med. 1996 Jul;2(4):417–428. [PMC free article] [PubMed] [Google Scholar]
  5. Altieri D. C. Proteases and protease receptors in modulation of leukocyte effector functions. J Leukoc Biol. 1995 Aug;58(2):120–127. doi: 10.1002/jlb.58.2.120. [DOI] [PubMed] [Google Scholar]
  6. Banati R. B., Rothe G., Valet G., Kreutzberg G. W. Detection of lysosomal cysteine proteinases in microglia: flow cytometric measurement and histochemical localization of cathepsin B and L. Glia. 1993 Feb;7(2):183–191. doi: 10.1002/glia.440070208. [DOI] [PubMed] [Google Scholar]
  7. Banik N. L. Pathogenesis of myelin breakdown in demyelinating diseases: role of proteolytic enzymes. Crit Rev Neurobiol. 1992;6(4):257–271. [PubMed] [Google Scholar]
  8. Bazzoni F., Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med. 1996 Jun 27;334(26):1717–1725. doi: 10.1056/NEJM199606273342607. [DOI] [PubMed] [Google Scholar]
  9. Benuck M., Marks N., Hashim G. A. Metabolic instability of myelin proteins. Breakdown of basic protein induced by brain cathepsin D. Eur J Biochem. 1975 Apr 1;52(3):615–621. doi: 10.1111/j.1432-1033.1975.tb04033.x. [DOI] [PubMed] [Google Scholar]
  10. Berlet H. H., Ilzenhöfer H. Elucidation of cathepsin B-like activity associated with extracts of human myelin basic protein. FEBS Lett. 1985 Jan 7;179(2):299–302. doi: 10.1016/0014-5793(85)80538-x. [DOI] [PubMed] [Google Scholar]
  11. Bernstein H. G., Wiederanders B., Rinne A., Dorn A. Distribution of cathepsin D immunoreactivity in the central nervous system of rat and selected brain regions of man. Acta Histochem. 1985;77(2):139–142. doi: 10.1016/S0065-1281(85)80073-8. [DOI] [PubMed] [Google Scholar]
  12. Bevec T., Stoka V., Pungercic G., Dolenc I., Turk V. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L. J Exp Med. 1996 Apr 1;183(4):1331–1338. doi: 10.1084/jem.183.4.1331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Boehme D. H., Umezawa H., Hashim G., Marks N. Treatment of experimental allergic encephalomyelitis with an inhibitor of cathepsin D (pepstatin). Neurochem Res. 1978 Apr;3(2):185–194. doi: 10.1007/BF00964059. [DOI] [PubMed] [Google Scholar]
  14. Brew B. J., Rosenblum M., Cronin K., Price R. W. AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann Neurol. 1995 Oct;38(4):563–570. doi: 10.1002/ana.410380404. [DOI] [PubMed] [Google Scholar]
  15. Budka H., Wiley C. A., Kleihues P., Artigas J., Asbury A. K., Cho E. S., Cornblath D. R., Dal Canto M. C., DeGirolami U., Dickson D. HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol. 1991 Apr;1(3):143–152. doi: 10.1111/j.1750-3639.1991.tb00653.x. [DOI] [PubMed] [Google Scholar]
  16. Bukrinsky M. I., Nottet H. S., Schmidtmayerova H., Dubrovsky L., Flanagan C. R., Mullins M. E., Lipton S. A., Gendelman H. E. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med. 1995 Feb 1;181(2):735–745. doi: 10.1084/jem.181.2.735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Böni J., Emmerich B. S., Leib S. L., Wiestler O. D., Schüpbach J., Kleihues P. PCR identification of HIV-1 DNA sequences in brain tissue of patients with AIDS encephalopathy. Neurology. 1993 Sep;43(9):1813–1817. doi: 10.1212/wnl.43.9.1813. [DOI] [PubMed] [Google Scholar]
  18. Cammer W., Bloom B. R., Norton W. T., Gordon S. Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination. Proc Natl Acad Sci U S A. 1978 Mar;75(3):1554–1558. doi: 10.1073/pnas.75.3.1554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Cammer W., Brosnan C. F., Basile C., Bloom B. R., Norton W. T. Complement potentiates the degradation of myelin proteins by plasmin: implications for a mechanism of inflammatory demyelination. Brain Res. 1986 Jan 29;364(1):91–101. doi: 10.1016/0006-8993(86)90990-x. [DOI] [PubMed] [Google Scholar]
  20. Chang J., Wigley F., Newcombe D. Neutral protease activation of peritoneal macrophage prostaglandin synthesis. Proc Natl Acad Sci U S A. 1980 Aug;77(8):4736–4740. doi: 10.1073/pnas.77.8.4736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Cohen S. R., Herndon R. M., McKhann G. M. Radioimmunoassay of myelin basic protein in spinal fluid. An index of active demyelination. N Engl J Med. 1976 Dec 23;295(26):1455–1457. doi: 10.1056/NEJM197612232952604. [DOI] [PubMed] [Google Scholar]
  22. Dahms P., Mentlein R. Purification of the main somatostatin-degrading proteases from rat and pig brains, their action on other neuropeptides, and their identification as endopeptidases 24.15 and 24.16. Eur J Biochem. 1992 Aug 15;208(1):145–154. doi: 10.1111/j.1432-1033.1992.tb17168.x. [DOI] [PubMed] [Google Scholar]
  23. Darmon A. J., Nicholson D. W., Bleackley R. C. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature. 1995 Oct 5;377(6548):446–448. doi: 10.1038/377446a0. [DOI] [PubMed] [Google Scholar]
  24. Deeks S. G., Smith M., Holodniy M., Kahn J. O. HIV-1 protease inhibitors. A review for clinicians. JAMA. 1997 Jan 8;277(2):145–153. [PubMed] [Google Scholar]
  25. Deiss L. P., Galinka H., Berissi H., Cohen O., Kimchi A. Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J. 1996 Aug 1;15(15):3861–3870. [PMC free article] [PubMed] [Google Scholar]
  26. Dickson D. W., Mattiace L. A., Kure K., Hutchins K., Lyman W. D., Brosnan C. F. Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. Lab Invest. 1991 Feb;64(2):135–156. [PubMed] [Google Scholar]
  27. Duan H., Orth K., Chinnaiyan A. M., Poirier G. G., Froelich C. J., He W. W., Dixit V. M. ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B. J Biol Chem. 1996 Jul 12;271(28):16720–16724. doi: 10.1074/jbc.271.28.16720. [DOI] [PubMed] [Google Scholar]
  28. Epstein L. G., Gendelman H. E. Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Ann Neurol. 1993 May;33(5):429–436. doi: 10.1002/ana.410330502. [DOI] [PubMed] [Google Scholar]
  29. Ferrante A. Tumor necrosis factor alpha potentiates neutrophil antimicrobial activity: increased fungicidal activity against Torulopsis glabrata and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme release. Infect Immun. 1989 Jul;57(7):2115–2122. doi: 10.1128/iai.57.7.2115-2122.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Gelman B. B., Dholakia S., Casper K., Kent T. A., Cloyd M. W., Freeman D., Jr Expansion of the cerebral ventricles and correlation with acquired immunodeficiency syndrome neuropathology in 232 patients. Arch Pathol Lab Med. 1996 Sep;120(9):866–871. [PubMed] [Google Scholar]
  31. Gelman B. B. Diffuse microgliosis associated with cerebral atrophy in the acquired immunodeficiency syndrome. Ann Neurol. 1993 Jul;34(1):65–70. doi: 10.1002/ana.410340112. [DOI] [PubMed] [Google Scholar]
  32. Gelman B. B., Papa L., Davis M. H., Gruenstein E. Decreased lysosomal dipeptidyl aminopeptidase I activity in cultured human skin fibroblasts in Duchenne's muscular dystrophy. J Clin Invest. 1980 Jun;65(6):1398–1406. doi: 10.1172/JCI109804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Gelman B. B., Rodriguez-Wolf M. G., Wen J., Kumar S., Campbell G. R., Herzog N. Siderotic cerebral macrophages in the acquired immunodeficiency syndrome. Arch Pathol Lab Med. 1992 May;116(5):509–516. [PubMed] [Google Scholar]
  34. Giulian D., Wendt E., Vaca K., Noonan C. A. The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2769–2773. doi: 10.1073/pnas.90.7.2769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Glass J. D., Fedor H., Wesselingh S. L., McArthur J. C. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol. 1995 Nov;38(5):755–762. doi: 10.1002/ana.410380510. [DOI] [PubMed] [Google Scholar]
  36. Halonen T., Kilpeläinen H., Pitkänen A., Riekkinen P. J. Lysosomal hydrolases in cerebrospinal fluid of multiple sclerosis patients. A follow-up study. J Neurol Sci. 1987 Jul;79(3):267–274. doi: 10.1016/0022-510x(87)90234-6. [DOI] [PubMed] [Google Scholar]
  37. Haque A. K., Cowan W. T., Smith J. H. The decedent affairs office. A unique centralized service. JAMA. 1991 Sep 11;266(10):1397–1399. [PubMed] [Google Scholar]
  38. Hausinger A., Volknandt W., Zimmermann H. Calcium-dependent endogenous proteolysis of the vesicle proteins synaptobrevin and synaptotagmin. Neuroreport. 1995 Mar 7;6(4):637–641. doi: 10.1097/00001756-199503000-00013. [DOI] [PubMed] [Google Scholar]
  39. Heyes M. P., Brew B. J., Martin A., Price R. W., Salazar A. M., Sidtis J. J., Yergey J. A., Mouradian M. M., Sadler A. E., Keilp J. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol. 1991 Feb;29(2):202–209. doi: 10.1002/ana.410290215. [DOI] [PubMed] [Google Scholar]
  40. Johnson R. T., Glass J. D., McArthur J. C., Chesebro B. W. Quantitation of human immunodeficiency virus in brains of demented and nondemented patients with acquired immunodeficiency syndrome. Ann Neurol. 1996 Mar;39(3):392–395. doi: 10.1002/ana.410390319. [DOI] [PubMed] [Google Scholar]
  41. King R. W., Deshaies R. J., Peters J. M., Kirschner M. W. How proteolysis drives the cell cycle. Science. 1996 Dec 6;274(5293):1652–1659. doi: 10.1126/science.274.5293.1652. [DOI] [PubMed] [Google Scholar]
  42. Kuida K., Lippke J. A., Ku G., Harding M. W., Livingston D. J., Su M. S., Flavell R. A. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science. 1995 Mar 31;267(5206):2000–2003. doi: 10.1126/science.7535475. [DOI] [PubMed] [Google Scholar]
  43. Laouar A., Villiers C., Sancéau J., Maison C., Colomb M., Wietzerbin J., Bauvois B. Inactivation of interleukin-6 in vitro by monoblastic U937 cell plasma membranes involves both protease and peptidyl-transferase activities. Eur J Biochem. 1993 Aug 1;215(3):825–831. doi: 10.1111/j.1432-1033.1993.tb18098.x. [DOI] [PubMed] [Google Scholar]
  44. Li C. J., Friedman D. J., Wang C., Metelev V., Pardee A. B. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science. 1995 Apr 21;268(5209):429–431. doi: 10.1126/science.7716549. [DOI] [PubMed] [Google Scholar]
  45. Liddil J. D., Dorr R. T., Scuderi P. Association of lysosomal activity with sensitivity and resistance to tumor necrosis factor in murine L929 cells. Cancer Res. 1989 May 15;49(10):2722–2728. [PubMed] [Google Scholar]
  46. Lipton S. A., Gendelman H. E. Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med. 1995 Apr 6;332(14):934–940. doi: 10.1056/NEJM199504063321407. [DOI] [PubMed] [Google Scholar]
  47. Lipton S. A. Similarity of neuronal cell injury and death in AIDS dementia and focal cerebral ischemia: potential treatment with NMDA open-channel blockers and nitric oxide-related species. Brain Pathol. 1996 Oct;6(4):507–517. doi: 10.1111/j.1750-3639.1996.tb00879.x. [DOI] [PubMed] [Google Scholar]
  48. Liu C. C., Young L. H., Young J. D. Lymphocyte-mediated cytolysis and disease. N Engl J Med. 1996 Nov 28;335(22):1651–1659. doi: 10.1056/NEJM199611283352206. [DOI] [PubMed] [Google Scholar]
  49. Liu Y., Fields R. D., Festoff B. W., Nelson P. G. Proteolytic action of thrombin is required for electrical activity-dependent synapse reduction. Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10300–10304. doi: 10.1073/pnas.91.22.10300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Liu Y., Fields R. D., Fitzgerald S., Festoff B. W., Nelson P. G. Proteolytic activity, synapse elimination, and the Hebb synapse. J Neurobiol. 1994 Mar;25(3):325–335. doi: 10.1002/neu.480250312. [DOI] [PubMed] [Google Scholar]
  51. Liuzzi G. M., Mastroianni C. M., Fanelli M., Massetti A. P., Vullo V., Delia S., Riccio P. Myelin degrading activity in the CSF of HIV-1-infected patients with neurological diseases. Neuroreport. 1994 Dec 30;6(1):157–160. doi: 10.1097/00001756-199412300-00040. [DOI] [PubMed] [Google Scholar]
  52. Marks N., Berg M. J., Benuck M. Preferential action of rat brain cathepsin B as a peptidyl dipeptidase converting pro-opioid oligopeptides. Arch Biochem Biophys. 1986 Sep;249(2):489–499. doi: 10.1016/0003-9861(86)90026-3. [DOI] [PubMed] [Google Scholar]
  53. Marks N., Grynbaum A., Benuck M. On the sequential cleavage of myelin basic protein by cathepsins A and D. J Neurochem. 1976 Sep;27(3):765–768. doi: 10.1111/j.1471-4159.1976.tb10405.x. [DOI] [PubMed] [Google Scholar]
  54. Marthinuss J., Andrade-Gordon P., Seiberg M. A secreted serine protease can induce apoptosis in Pam212 keratinocytes. Cell Growth Differ. 1995 Jul;6(7):807–816. [PubMed] [Google Scholar]
  55. Martin S. J., Amarante-Mendes G. P., Shi L., Chuang T. H., Casiano C. A., O'Brien G. A., Fitzgerald P., Tan E. M., Bokoch G. M., Greenberg A. H. The cytotoxic cell protease granzyme B initiates apoptosis in a cell-free system by proteolytic processing and activation of the ICE/CED-3 family protease, CPP32, via a novel two-step mechanism. EMBO J. 1996 May 15;15(10):2407–2416. [PMC free article] [PubMed] [Google Scholar]
  56. Masliah E., Ge N., Morey M., DeTeresa R., Terry R. D., Wiley C. A. Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab Invest. 1992 Mar;66(3):285–291. [PubMed] [Google Scholar]
  57. Mentlein R., Dahms P. Endopeptidases 24.16 and 24.15 are responsible for the degradation of somatostatin, neurotensin, and other neuropeptides by cultivated rat cortical astrocytes. J Neurochem. 1994 Jan;62(1):27–36. doi: 10.1046/j.1471-4159.1994.62010027.x. [DOI] [PubMed] [Google Scholar]
  58. Miyazawa K., Shimomura T., Kitamura N. Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator. J Biol Chem. 1996 Feb 16;271(7):3615–3618. doi: 10.1074/jbc.271.7.3615. [DOI] [PubMed] [Google Scholar]
  59. Morgan B. P. Physiology and pathophysiology of complement: progress and trends. Crit Rev Clin Lab Sci. 1995;32(3):265–298. doi: 10.3109/10408369509084686. [DOI] [PubMed] [Google Scholar]
  60. Morton P. A., Zacheis M. L., Giacoletto K. S., Manning J. A., Schwartz B. D. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells. J Immunol. 1995 Jan 1;154(1):137–150. [PubMed] [Google Scholar]
  61. Müllberg J., Durie F. H., Otten-Evans C., Alderson M. R., Rose-John S., Cosman D., Black R. A., Mohler K. M. A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor. J Immunol. 1995 Dec 1;155(11):5198–5205. [PubMed] [Google Scholar]
  62. Müller F. Reactive oxygen intermediates and human immunodeficiency virus (HIV) infection. Free Radic Biol Med. 1992 Dec;13(6):651–657. doi: 10.1016/0891-5849(92)90039-j. [DOI] [PubMed] [Google Scholar]
  63. Nakajima K., Tsuzaki N., Shimojo M., Hamanoue M., Kohsaka S. Microglia isolated from rat brain secrete a urokinase-type plasminogen activator. Brain Res. 1992 Apr 17;577(2):285–292. doi: 10.1016/0006-8993(92)90285-h. [DOI] [PubMed] [Google Scholar]
  64. Neurath H., Walsh K. A. Role of proteolytic enzymes in biological regulation (a review). Proc Natl Acad Sci U S A. 1976 Nov;73(11):3825–3832. doi: 10.1073/pnas.73.11.3825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Nottet H. S., Jett M., Flanagan C. R., Zhai Q. H., Persidsky Y., Rizzino A., Bernton E. W., Genis P., Baldwin T., Schwartz J. A regulatory role for astrocytes in HIV-1 encephalitis. An overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-alpha by activated HIV-1-infected monocytes is attenuated by primary human astrocytes. J Immunol. 1995 Apr 1;154(7):3567–3581. [PubMed] [Google Scholar]
  66. Olano J. P., Wolf D., Keherly M., Gelman B. B. Quantifying apoptosis in banked human brains using flow cytometry. J Neuropathol Exp Neurol. 1996 Nov;55(11):1164–1172. doi: 10.1097/00005072-199611000-00008. [DOI] [PubMed] [Google Scholar]
  67. Persidsky Y., Limoges J., McComb R., Bock P., Baldwin T., Tyor W., Patil A., Nottet H. S., Epstein L., Gelbard H. Human immunodeficiency virus encephalitis in SCID mice. Am J Pathol. 1996 Sep;149(3):1027–1053. [PMC free article] [PubMed] [Google Scholar]
  68. Petito C. K., Roberts B. Evidence of apoptotic cell death in HIV encephalitis. Am J Pathol. 1995 May;146(5):1121–1130. [PMC free article] [PubMed] [Google Scholar]
  69. Price R. W., Sidtis J. J., Brew B. J. AIDS dementia complex and HIV-1 infection: a view from the clinic. Brain Pathol. 1991 Apr;1(3):155–162. doi: 10.1111/j.1750-3639.1991.tb00655.x. [DOI] [PubMed] [Google Scholar]
  70. Quan L. T., Tewari M., O'Rourke K., Dixit V., Snipas S. J., Poirier G. G., Ray C., Pickup D. J., Salvesen G. S. Proteolytic activation of the cell death protease Yama/CPP32 by granzyme B. Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):1972–1976. doi: 10.1073/pnas.93.5.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Reyes V. E., Lu S., Humphreys R. E. Cathepsin B cleavage of Ii from class II MHC alpha- and beta-chains. J Immunol. 1991 Jun 1;146(11):3877–3880. [PubMed] [Google Scholar]
  72. Roche P. A., Cresswell P. Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3150–3154. doi: 10.1073/pnas.88.8.3150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Sappino A. P., Madani R., Huarte J., Belin D., Kiss J. Z., Wohlwend A., Vassalli J. D. Extracellular proteolysis in the adult murine brain. J Clin Invest. 1993 Aug;92(2):679–685. doi: 10.1172/JCI116637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Schmidbauer M., Huemer M., Cristina S., Trabattoni G. R., Budka H. Morphological spectrum, distribution and clinical correlation of white matter lesions in AIDS brains. Neuropathol Appl Neurobiol. 1992 Oct;18(5):489–501. doi: 10.1111/j.1365-2990.1992.tb00816.x. [DOI] [PubMed] [Google Scholar]
  75. Schnyder J., Baggiolini M. Secretion of lysosomal hydrolases by stimulated and nonstimulated macrophages. J Exp Med. 1978 Aug 1;148(2):435–450. doi: 10.1084/jem.148.2.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Seeds N. W., Williams B. L., Bickford P. C. Tissue plasminogen activator induction in Purkinje neurons after cerebellar motor learning. Science. 1995 Dec 22;270(5244):1992–1994. doi: 10.1126/science.270.5244.1992. [DOI] [PubMed] [Google Scholar]
  77. Selmaj K., Raine C. S., Farooq M., Norton W. T., Brosnan C. F. Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J Immunol. 1991 Sep 1;147(5):1522–1529. [PubMed] [Google Scholar]
  78. Sinclair E., Gray F., Ciardi A., Scaravilli F. Immunohistochemical changes and PCR detection of HIV provirus DNA in brains of asymptomatic HIV-positive patients. J Neuropathol Exp Neurol. 1994 Jan;53(1):43–50. doi: 10.1097/00005072-199401000-00006. [DOI] [PubMed] [Google Scholar]
  79. Smirnova I. V., Ho G. J., Fenton J. W., 2nd, Festoff B. W. Extravascular proteolysis and the nervous system: serine protease/serpin balance. Semin Thromb Hemost. 1994;20(4):426–432. doi: 10.1055/s-2007-1001931. [DOI] [PubMed] [Google Scholar]
  80. Smyth M. J., Trapani J. A. Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol Today. 1995 Apr;16(4):202–206. doi: 10.1016/0167-5699(95)80122-7. [DOI] [PubMed] [Google Scholar]
  81. Takahashi K., Wesselingh S. L., Griffin D. E., McArthur J. C., Johnson R. T., Glass J. D. Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol. 1996 Jun;39(6):705–711. doi: 10.1002/ana.410390606. [DOI] [PubMed] [Google Scholar]
  82. Tyor W. R., Glass J. D., Griffin J. W., Becker P. S., McArthur J. C., Bezman L., Griffin D. E. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol. 1992 Apr;31(4):349–360. doi: 10.1002/ana.410310402. [DOI] [PubMed] [Google Scholar]
  83. Vey E., Burger D., Dayer J. M. Expression and cleavage of tumor necrosis factor-alpha and tumor necrosis factor receptors by human monocytic cell lines upon direct contact with stimulated T cells. Eur J Immunol. 1996 Oct;26(10):2404–2409. doi: 10.1002/eji.1830261021. [DOI] [PubMed] [Google Scholar]
  84. Watanabe N., Niitsu Y., Neda H., Sone H., Yamauchi N., Maeda M., Urushizaki I. Cytocidal mechanism of TNF: effects of lysosomal enzyme and hydroxyl radical inhibitors on cytotoxicity. Immunopharmacol Immunotoxicol. 1988;10(1):109–116. doi: 10.3109/08923978809014405. [DOI] [PubMed] [Google Scholar]
  85. Wesselingh S. L., Power C., Glass J. D., Tyor W. R., McArthur J. C., Farber J. M., Griffin J. W., Griffin D. E. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol. 1993 Jun;33(6):576–582. doi: 10.1002/ana.410330604. [DOI] [PubMed] [Google Scholar]
  86. Wiestler O. D., Leib S. L., Brüstle O., Spiegel H., Kleihues P. Neuropathology and pathogenesis of HIV encephalopathies. Acta Histochem Suppl. 1992;42:107–114. [PubMed] [Google Scholar]
  87. Wiley C. A., Achim C. Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol. 1994 Oct;36(4):673–676. doi: 10.1002/ana.410360422. [DOI] [PubMed] [Google Scholar]
  88. Wiley C. A., Masliah E., Achim C. L. Measurement of CNS HIV burden and its association with neurologic damage. Adv Neuroimmunol. 1994;4(3):319–325. doi: 10.1016/s0960-5428(06)80272-x. [DOI] [PubMed] [Google Scholar]
  89. Wiley C. A. Polymerase chain reaction in situ hybridization--opening Pandora's box? Ann Neurol. 1996 Jun;39(6):691–692. doi: 10.1002/ana.410390603. [DOI] [PubMed] [Google Scholar]
  90. Williams M. S., Henkart P. A. Apoptotic cell death induced by intracellular proteolysis. J Immunol. 1994 Nov 1;153(9):4247–4255. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES